AMI DALAL: Open Payments
NPI 1598948184 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,488 in 128 payments from 16 companies in 2025. Trend: 2023 $6,593 · 2024 $1,360 · 2025 $2,488
Food & beverage: $2,488
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 23 | $578 |
| Galderma Laboratories, L.P. | 21 | $527 |
| Journey Medical Corporation | 17 | $234 |
| LEO Pharma Inc. | 6 | $226 |
| E.R. Squibb & Sons, L.L.C. | 21 | $189 |
| Organon LLC | 8 | $130 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $121 |
| ABBVIE INC. | 6 | $103 |
| Janssen Biotech, Inc. | 5 | $97 |
| Amgen Inc. | 5 | $90 |
Products named: Zoryve, NEMLUVIO, ANZUPGO, Sotyktu, ILUMYA, TREMFYA, OTEZLA, SKYRIZI.
Industry payments across NY — which companies pay providers there.
